SEC 13F Intelligence

Managers / Q1 2024 · view latest →

325 CAPITAL LLC

CIK 0001873893 · 757 THIRD AVENUE, 20TH FLOOR, NEW YORK, NY, 10017 · 212-376-5325

Reported Value
$217M
Q1 2024
Positions
12
Filings on Record
18
2019–present window
Filed
May 15, 2024
original filing

Summary

325 Capital LLC reported $217M in U.S.-listed holdings across 12 positions for Q1 2024.

The portfolio is heavily concentrated: BLBD alone accounts for 20.6% of reported value.

Compared with Q4 2023, the fund opened 0 new positions and exited 1.

Portfolio Metrics

Turnover
+6.0%
vs prior filed quarter
Top-10 Concentration
+94.7%
share of reported value
Largest Position
+20.6%
Blue Bird

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $102MQ4 ’21Q1 ’22: $132MQ2 ’22: $108MQ3 ’22: $86MQ3 ’22Q4 ’22: $92MQ1 ’23: $114MQ2 ’23: $152MQ2 ’23Q3 ’23: $121MQ4 ’23: $202MQ1 ’24: $217MQ1 ’24Q2 ’24: $238MQ3 ’24: $236MQ4 ’24: $259MQ4 ’24Q1 ’25: $241MQ2 ’25: $253MQ3 ’25: $329MQ3 ’25Q4 ’25: $285MQ1 ’26: $274Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 86.8%ETP: 13.2%
  • Common Stock · 86.8% · $188M
  • ETP · 13.2% · $29M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DASEKE INCSOLD OUT−833.0K0−$7M$0
LFCRLIFECORE BIOMEDICAL INCADDED+133.6K1.34M−$352,563$7M
BLBDBLUE BIRD CORPHELD+01.16M+$13M$45M
APEIAMERICAN PUB ED INCHELD+01.28M+$6M$18M
BTMDBIOTE CORPHELD+03.77M+$3M$22M
ATROASTRONICS CORPHELD+01.64M+$3M$31M
ASTHASTRANA HEALTH INCHELD+0592.8K+$2M$25M
MPAAMOTORCAR PTS AMER INCHELD+01.41M−$2M$11M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

12 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BLBDBLUE BIRD CORPhistory →COM20.61%$45M1.16M
2ATROASTRONICS CORPhistory →COM14.39%$31M1.64M
3SGOVISHARES TRhistory →0-3 MNTH TREASRY13.21%$29M284.1K
4ASTHASTRANA HEALTH INChistory →COM NEW11.49%$25M592.8K
5BTMDBIOTE CORPhistory →CLASS A COM10.09%$22M3.77M
6APEIAMERICAN PUB ED INChistory →COM8.41%$18M1.28M
7MPAAMOTORCAR PTS AMER INChistory →COM5.22%$11M1.41M
8IDCCINTERDIGITAL INChistory →COM4.62%$10M94.0K
9COHUCOHU INChistory →COM3.34%$7M216.8K
10LFCRLIFECORE BIOMEDICAL INChistory →COM3.29%$7M1.34M
11HTLDHEARTLAND EXPRESS INChistory →COM2.89%$6M523.4K
12TACTTRANSACT TECHNOLOGIES INChistory →COM2.45%$5M1.01M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$274M12May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$285M13Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$329M12Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$253M11Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$241M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$259M12Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M11Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$238M13Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$217M12May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$202M13Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$121M8Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$152M9Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$114M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$92M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$86M8Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$108M10Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$132M9May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$102M9Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.